| Angiogenin and gestational trophoblastic tumors, a promising prognostic marker. | |
| | |
MedLine Citation:
|
PMID: 12705339 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The aim of this study was to evaluate the diagnostic and prognostic values of serum angiogenin concentration in cases with gestational trophoblastic diseases (GTDs). Seventy-two patients with GTDs and 20 first trimester healthy pregnant women (controls) participated in this study. According to the WHO scoring system, GTDs were subgrouped into 24 hydatiform mole spontaneous regression (HMSR), 18 postmolar gestational trophoblastic tumors of high risk (PMHR), 16 low-risk choriocarcinoma, and 14 high-risk choriocarcinoma. Before treatment, a blood sample from each case was assayed for human chorionic gonadotrophin , subunit (hCGb) by radioimmunoassay and angiogenin by enzyme immunoassay. Follow-up hCGb and angiogenin assays were carried out for 1 year after treatment. Pretreatment of abnormal values of serum angiogenin (> 711 ng/ml, upper 95% confidence interval of controls) was encountered in 100% of PMHR cases compared to no single case of HMSR. Serum angiogenin levels in low- and high-risk cases with choriocarcinoma were significantly higher than in controls. Abnormal high values were encountered in 25% and 86% of cases, respectively. None of the low-risk cases exceeded 920 ng/ml, while 72% of high-risk cases exceeded this value. Serial angiogenin assays were correlated with disease progression and were positively correlated with serum hCGb (r = 0.75, p < 0.01). In conclusion, serum angiogenin may be a valuable marker of differential diagnosis of GTDs and its serial measurements are suggestive of remission and effective therapeutic intervention or disease progression. |
| | |
Authors:
|
Mohamed Shaarawy; Samira Y El-Mallah; Mamdouh Sheiba |
Related Documents
:
|
12777999 - Gastric carcinoma with lymphoid stroma: incidence of ebv and helicobacter pylori infect... 21278179 - The transition to ivus-guided ivc filter deployment in the nontrauma patients. 12967499 - Severe acute respiratory syndrome: temporal stability and geographic variation in case-... 16428259 - The optimal ratio of cases to controls for estimating the classification accuracy of a ... 12172899 - A validation of information on occupation--data from a nested case-control study. 2347229 - A new device that allows synchronous intermittent inspiratory chest tube occlusion with... 15273199 - Desbaric air embolism during diving: an unusual complication of osler-weber-rendu disease. 18942309 - Tubercular synovitis mimicking rheumatoid nodules. 1757069 - Lethal arthrogryposis multiplex congenita: a pathological study of 21 cases. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study |
Journal Detail:
|
Title: Clinical chemistry and laboratory medicine : CCLM / FESCC Volume: 41 ISSN: 1434-6621 ISO Abbreviation: Clin. Chem. Lab. Med. Publication Date: 2003 Mar |
Date Detail:
|
Created Date: 2003-04-22 Completed Date: 2003-12-03 Revised Date: 2011-07-19 |
Medline Journal Info:
|
Nlm Unique ID: 9806306 Medline TA: Clin Chem Lab Med Country: Germany |
Other Details:
|
Languages: eng Pagination: 306-10 Citation Subset: IM |
Affiliation:
|
Endocrinology and Maternal Biochemistry Laboratories, Department of Obstetrics and Gynecology, Faculty of Medicine, Cairo University, Cairo, Egypt. shaarawy@mednet3.camed.eun.eg |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Case-Control Studies Choriocarcinoma / diagnosis Chorionic Gonadotropin, beta Subunit, Human / blood Diagnosis, Differential Disease Progression Female Gestational Trophoblastic Neoplasms / blood, diagnosis* Humans Hydatidiform Mole / diagnosis Pregnancy Pregnancy Trimester, First Prognosis Ribonuclease, Pancreatic / blood* Risk Factors Tumor Markers, Biological / blood* Uterine Neoplasms / blood, diagnosis* |
| Chemical | |
Reg. No./Substance:
|
0/Chorionic Gonadotropin, beta Subunit, Human; 0/Tumor Markers, Biological; EC 3.1.27.-/angiogenin; EC 3.1.27.5/Ribonuclease, Pancreatic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of partial proteolysis on the activation energy of beta-n-acetylhexosaminidase precursor and ...
Next Document: Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis.